During a hearing before the House Energy Committee examining the drug supply chain, Association for Accessible Medicines (AAM) President/CEO Chester Davis argued that generic drug markets are fundamentally different than those for innovators and have increased supply chain pressures, “For every $100 spent on dispensing generic medicines in this country, approximately $65 goes to the distribution and reimbursement of those products by the members of the supply chain.” Opening statements from other industry stakeholders are available online.
INTERNATIONAL PHARMACEUTICAL QUALITY
Inside the Global Regulatory Dialogue
